Lex/EU lobbying/Breakthrough T1D
Organisation · Transparency Register · 623930744946-01

Breakthrough T1D

EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.

Disclosed meetings3 (1 EC · 2 EP)
Register no.623930744946-01
Period2025-06-03 → 2026-06-10
In short

Breakthrough T1D has 3 disclosed EU lobbying meetings from 2025-06-03 to 2026-06-10: 1 with the European Commission and 2 with Members of the European Parliament. Source: EU Transparency Register no. 623930744946-01, Commission disclosures and MEP declarations.

Does Breakthrough T1D lobby on the files that affect you?
Run a free exposure scan — see where your company overlaps with this footprint, ranked across the EU corpus.

Lobbying profile

as declared 2025-12-01
Category
Non-governmental organisations, platforms and networks and similar
Legal status
Nonprofit organization
Declared lobbying cost
€0
Lobbying FTEs
4
LobbyFacts / Transparency Register source ↗

Files it’s lobbying on

The org's disclosed policy areas, ranked by number of meetings.

Finance1 mtgs
A disclosed meeting is contact, not influence. Counts are of disclosed meetings only.

Declared fields of interest

Public health · Research and innovation

At a glance

The officials and MEPs most often met, by disclosed-meeting count.

Commission officials
  • Kasia Jurczak1

Disclosed meetings

Newest first. EC = European Commission, EP = Member of the European Parliament.

  • 2026-06-10EPVERYGA Aurelijus
    Exchange of Views on the EU Biotech Actsource ↗
  • 2026-04-23EPWÖLKEN Tiemo
    Biotech Actsource ↗
  • 2025-06-03ECKasia Jurczak · Head of Unit
    Presentation of Breakthrough T1D, the US based, tax-exempt nonprofit organisation that invests in type 1 diabetes research, and discussion on its role as a research funder supporting multicountry clinical trials within the EUsource ↗

Frequently asked

How many EU lobbying meetings has Breakthrough T1D disclosed?

Breakthrough T1D (EU Transparency Register no. 623930744946-01) appears in 3 disclosed meetings with EU officials and MEPs between 2025-06-03 and 2026-06-10: 1 with the European Commission and 2 with Members of the European Parliament.

What does Breakthrough T1D lobby on?

Breakthrough T1D's disclosed EU meetings most often concern Finance. Every meeting and its topic is listed with its official source on this page.

Who does Breakthrough T1D meet in Brussels?

Across its disclosed meetings, Breakthrough T1D has met Commission officials including Kasia Jurczak, and MEPs including VERYGA Aurelijus, WÖLKEN Tiemo. These are counts of officially disclosed meetings, not a measure of influence.

Primary sources

Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.

Related on the graph

The same footprint, mapped onto the topics and files it touches.

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

See your company’s overlap with Breakthrough T1Dand the rest of the corpus.

Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.